Related Experiment Videos
Hypercalcemia and squamous cell carcinoma complicating chronic osteomyelitis
A J Fenton1, A R King, I R Reid
1Auckland Hospital, New Zealand.
Australian and New Zealand Journal of Medicine
|August 1, 1989
Summary
A rare case details squamous cell carcinoma developing in chronic osteomyelitis, leading to a unique instance of humoral hypercalcemia of malignancy. This condition was successfully managed with bisphosphonates and tumor resection.
Area of Science:
- Oncology
- Endocrinology
- Orthopedics
Background:
- Chronic osteomyelitis can present complex complications.
- Malignancies can arise in long-standing inflammatory conditions.
- Humoral hypercalcemia of malignancy (HCM) is a serious paraneoplastic syndrome.
Observation:
- A patient with chronic osteomyelitis developed squamous cell carcinoma within a sinus tract.
- This malignancy was associated with HCM, a previously undescribed complication in this context.
- Misinterpretation of parathyroid hormone levels led to a misdiagnosis of hyperparathyroidism.
Findings:
- Standard treatments like saline diuresis, mithramycin, and phosphate supplements failed to control hypercalcemia.
- Intravenous bisphosphonate (APD) and surgical tumor resection provided successful long-term management.
- This case highlights a novel association between squamous cell carcinoma in osteomyelitis and HCM.
Implications:
- Recognizing HCM in patients with chronic osteomyelitis and associated malignancies is crucial for accurate diagnosis.
- Bisphosphonates represent an effective therapeutic option for managing HCM in such complex cases.
- This case expands the understanding of paraneoplastic syndromes and their management in chronic inflammatory conditions.